首页> 外文期刊>Molecular pharmaceutics >Encapsulation of Ibuprofen in CD-MOF and Related Bioavailability Studies
【24h】

Encapsulation of Ibuprofen in CD-MOF and Related Bioavailability Studies

机译:在CD-MOF和相关生物利用度研究中封装布洛芬

获取原文
获取原文并翻译 | 示例
       

摘要

Although ibuprofen is one of the most widely used nonsteroidal anti-inflammatory drugs (NSAIDs), it exhibits poor solubility in aqueous and physiological environments as a free acid. In order to improve its oral bioavailability and rate of uptake, extensive research into the development of new formulations of ibuprofen has been undertaken, including the use of excipients as well as ibuprofen salts, such as ibuprofen lysinate and ibuprofen, sodium salt. The ultimate goals of these studies are to reduce the time required for maximum uptake of ibuprofen, as this period of time is directly proportional to the rate of onset of analgesic/anti-inflammatory effects, and to increase the half-life of the drug within the body; that is, the duration of action of the effects of the drug. Herein, we present a pharmaceutical cocrystal of ibuprofen and the biocompatible metal-organic framework called CD-MOF. This metal-organic framework (MOF) is based upon gamma-cyclodextrin (gamma-CD) tori that are coordinated to alkali metal cations (e.g., K+ ions) on both their primary and secondary faces in an alternating manner to form a porous framework built up from (gamma-CD)(6) cubes. We show that ibuprofen can be incorporated within CD-MOF-1 either by (i) a crystallization process using the potassium salt of ibuprofen as the alkali cation source for production of the MOF or by (ii) absorption and deprotonation of the free-acid, leading to an uptake of 23-26 wt % of ibuprofen within the CD-MOF. In vitro viability studies revealed that the CD-MOF is inherently not affecting the viability of the cells with no IC50 value determined up to a concentration of 100 mu M. Bioavailability investigations were conducted on mice, and the ibuprofen/CD-MOF pharmaceutical cocrystal was compared to control samples of the potassium salt of ibuprofen in the presence and absence of gamma-CD. From these animal studies, we observed that the ibuprofen/CD-MOF-1 cocrystal exhibits the same rapid uptake of ibuprofen as the ibuprofen potassium salt control sample with a peak plasma concentration observed within 20 min, and the cocrystal has the added benefit of a 100% longer half-life in blood plasma samples and is intrinsically less hygroscopic than the pure salt form.
机译:尽管布洛芬是最广泛使用的非甾体抗炎药(NSAIDS)之一,但它在水性和生理环境中表现出差的溶解度,作为游离酸。为了提高其口腔生物利用度和吸收率,已经进行了广泛的促进布洛芬制剂的发展,包括使用赋形剂以及布洛芬透素和布洛芬,钠盐等赋予布洛芬盐。这些研究的最终目标是减少最大吸收布洛芬所需的时间,因为这段时间与镇痛/抗炎作用的发作速率直接成比例,并增加药物的半衰期身体;也就是说,药物效应的作用持续时间。在此,我们介绍了布洛芬的药物酰基和称为CD-MOF的生物相容性金属 - 有机骨架。该金属有机框架(MOF)基于γ-环糊精(γ-CD)托尔,其在其初级和次级面上与碱金属阳离子(例如,K +离子)以交替的方式形成构建的多孔框架从(Gamma-CD)(6)立方体。我们表明,布洛芬可以通过(i)使用布洛芬的钾盐作为碱阳离子来源的结晶方法作为用于生产MOF的碱金属盐或(ii)的吸收和游离酸的去质子,导致CD-MOF内的23-26重量%的布洛芬的摄取。在体外的活力研究表明,CD-MOF固有地没有影响细胞的活力,没有确定浓度为100μmM的IC50值。在小鼠上进行生物利用度调查,并且对小鼠进行生物利用度调查,并且含有布洛芬/ CD-Mof药物Cocrystal的生物利用度研究与γ-CD的存在和不存在的布洛芬钾盐对照样品相比。从这些动物研究中,我们观察到的是布洛芬/ CD-MOF-1个COCRYSTAL表现出与峰值血浆浓度在20分钟内观察到的峰值血浆浓度的同样快速摄取,并且通过含量的额外效益在血浆样品中100%延长半衰期,并且本质上的吸湿性比纯盐形式更少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号